These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26798188)

  • 1. Correlation and Significance of Urinary Soluble Fas and Vascular Endothelial Growth Factor in Bladder Urothelial Cancer.
    Yang H; Wang Z; Guo Y; Wang Z
    Dis Markers; 2015; 2015():383509. PubMed ID: 26798188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is urinary soluble Fas an independent predictor of non-muscle-invasive bladder cancer? A prospective chart study.
    Yang H; Li H; Wang Z; Gao J; Guo Y
    Urol Int; 2013; 91(4):456-61. PubMed ID: 23948854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of the VEGF level in urinary bladder carcinoma.
    Sankhwar M; Sankhwar SN; Abhishek A; Rajender S
    Cancer Biomark; 2015; 15(4):349-55. PubMed ID: 25792473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer.
    Svatek RS; Herman MP; Lotan Y; Casella R; Hsieh JT; Sagalowsky AI; Shariat SF
    Cancer; 2006 Apr; 106(8):1701-7. PubMed ID: 16541433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of urinary soluble Fas in screening for bladder cancer.
    Srivastava AK; Singh PK; Singh D; Dalela D; Rath SK; Bhatt ML
    Asia Pac J Clin Oncol; 2016 Jun; 12(2):e215-21. PubMed ID: 24576318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer.
    Wang YH; Yeh SD; Wu MM; Liu CT; Shen CH; Shen KH; Pu YS; Hsu LI; Chiou HY; Chen CJ
    J Hazard Mater; 2013 Nov; 262():1139-46. PubMed ID: 23009795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates.
    Crew JP; O'Brien T; Bicknell R; Fuggle S; Cranston D; Harris AL
    J Urol; 1999 Mar; 161(3):799-804. PubMed ID: 10022687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):571-6. PubMed ID: 9679930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationships of serum selenium, VEGF and sFas levels in leukemia patients].
    Wang Y; Liu FQ; Wu YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):759-62. PubMed ID: 18718055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible role of telomerase and sFas in pathogenesis of various bladder lesions associated with schistosomiasis.
    Shaker OG; Hammam O; Salehd A; el-Leithy T; Wishahi M
    Clin Biochem; 2009 Jun; 42(9):864-72. PubMed ID: 19272297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components.
    Ioachim E; Michael MC; Salmas M; Damala K; Tsanou E; Michael MM; Malamou-Mitsi V; Stavropoulos NE
    BMC Cancer; 2006 May; 6():140. PubMed ID: 16732887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection.
    Urquidi V; Goodison S; Kim J; Chang M; Dai Y; Rosser CJ
    Urology; 2012 May; 79(5):1185.e1-6. PubMed ID: 22386755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive values of urinary bladder tumor markers survivin and soluble-Fas comparison with cystoscopy and bladder tumor antigen.
    Ganas V; Kalaitzis C; Sountoulides P; Giannakopoulos S; Touloupidis S
    Minerva Urol Nefrol; 2012 Dec; 64(4):279-85. PubMed ID: 23288215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALKBH3 contributes to survival and angiogenesis of human urothelial carcinoma cells through NADPH oxidase and tweak/Fn14/VEGF signals.
    Shimada K; Fujii T; Tsujikawa K; Anai S; Fujimoto K; Konishi N
    Clin Cancer Res; 2012 Oct; 18(19):5247-55. PubMed ID: 22850567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD 10 expression intensity in various grades and stages of urothelial carcinoma of urinary bladder.
    Atique M; Abbasi MS; Jamal S; Khadim MT; Akhtar F; Jamal N
    J Coll Physicians Surg Pak; 2014 May; 24(5):351-5. PubMed ID: 24848395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of vascular endothelial growth factors A, C and D as indicators of lymphangiogenesis and angiogenesis in invasive and non-invasive urothelial carcinoma bladder.
    Khadim MT; Ahmed SA; Khan FA; Ikram A; Shaikh SY
    J Pak Med Assoc; 2015 Aug; 65(8):851-6. PubMed ID: 26228330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma.
    Sun YW; Xuan Q; Shu QA; Wu SS; Chen H; Xiao J; Xiang P; Zhu YP; Wang FL; Zhao ST
    Genet Mol Res; 2013 Apr; 12(2):1045-53. PubMed ID: 23613251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of vascular endothelial growth factor in transitional cell carcinoma of urinary bladder is correlated with cancer progression.
    Yang CC; Chu KC; Yeh WM
    Urol Oncol; 2004; 22(1):1-6. PubMed ID: 14969795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas.
    Donmez G; Sullu Y; Baris S; Yildiz L; Aydin O; Karagoz F; Kandemir B
    Pathol Res Pract; 2009; 205(12):854-7. PubMed ID: 19762163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.